PharmaTalkRadio

Dr Simeone, the national PI leader on the adaptive platform trial on metastatic pancreatic cancer, Precision Promise, share her vision on embarking upon and building a new clinical-trial ecosystem.

Speaker:

Diane M Simeone, MD, Perlmutter Professor of Surgery and Pathology, NYU Langone, Director of the Pancreatic Cancer Center, NYU Perlmutter Cancer Center

University Hospital’s Chief Strategic Integration and Health Equity Officer, Dr Chris Pernell, participated in the Moderna COVID vaccine trial. Dr Pernell tells us what we can do to improve health equity in care and research.

Speakers

Sharon Hanlon, Group Director, Clinical Trial Engagement & Enrollment, Bristol-Myers SquibbChris Pernell, MD, MPH, FACPM, Chief Strategic Integration and Health Equity Officer, University Hospital

Amgen leadership joins Patients as Partners to discuss their RISE (Representation in Clinical Research) Initiative that is transforming clinical trial diversity at Amgen. Key topics include:

The development of RISE, what it took to get off the ground

Working with internal global development operations and other key groups by diversifying investigators and collaborating with those who serve diverse patient areas at clinical trial sites

Collaborations with non-profits in communities that can help remove barriers to participation in clinical trials

Partnering with influential community leaders to regain trust within communities

Key learnings to help other stakeholders adapt, adjust and build on their current diversity and community engagement initiatives

Ponda Motsepe-Ditshego, MBChB, VP, Global Medical Therapeutic Area Head, General Medicine & Global Chair, Amgen Black Employee Network (ABEN), Amgen

Jude Ngang, PharmD, Executive Director, Representation in Clinical Research (RISE), Amgen

Moderated by:

Hassan Kadim, Director, Head of Clinical Trial Business Capabilities, Global Development Operations, BMS

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

Drs Janet Woodcock and Laura Esserman discuss why integrating clinical research and care is so critical and explore how we can get patients more access to clinical trials. Together they address:

What is missing for the vision of integrating care and researchReal world dataPlatform trials and adaptive design solutionsHarmonizing data collectionNew models for covering costDeveloping a centralized IRBSimplifying the trial activation processIntegrating data collection with clinical care help from community settingsEarly endpoints and their ability to drive de-escalation and escalationWorkforce developmentMindsets, models, tools and more

Speakers:

Laura Esserman, MD, Professor of Surgery & Radiology, University of California, San Francisco / Director, UCSF Carol Franc Buck Breast, Cancer CenterJanet Woodcock, MD, Acting Commissioner of Food and Drugs, FDA

Non-profits can influence the community in a way that sponsors and site organizations cannot. In this session, Javara and Greater Gift present a partnership case study and show how they were able to achieve community access as a team.

Speakers:

Amanda Wright, Co-Founder & Chief Development Officer, JavaraJennifer Byrne, Founder, Greater Gift / CEO, JavaraKushal Gohil, MBA, SVP, Corporate Strategy & Innovation, Parexel

In this session, panelists share best practices in raising awareness for clinical trials and improving patient satisfaction by educating patients and non-research physicians on the clinical trial process.

Speakers:

Lora Black, RN, MPH, OCN, CCRP, Executive Director, Clinical Research, Sanford HealthRobert Loll, SVP, Business Development & Strategic Planning, PraxisIrfan Khan, MD, Founder & CEO, Circuit Clinical

In this podcast, you will hear a panel discussion moderated by Dr Cindy Wu, AbbVie, from the 2022 PODD Conference regarding opportunities for long acting injectable biologics, stability, manufacturing processes, storage, release periods, and new delivery technologies including conjugate-based delivery.

Panelists include:

Brent A Buchine, PhD, Windgap MedicalFrederic Dargelas, PhD, MBA, DelSiTechMarc Hendriks, PhD, DSM BiomedicalMatthew O’Brien, PhD, Genentech

To learn more about the PODD Conference, please visit PODDConference.com.

In this session, panelists from pharma and healthcare share perspectives on innovations in decentralized clinical trial technologies that have and have not worked during and throughout COVID. They also discuss:

How we are bringing forth trial options to people on their own terms and getting patient inputCreating flexible systems that don’t increase undue burden on hospitals and sitesWhat hasn’t worked and whyManaging cost and spend

Speakers:

Sharon Hanlon, Head, Clinical Trial Engagement & Enrolment, Bristol Myers SquibbChristina Brennan, MD, MBA, VP, Clinical Research, Northwell HealthJamie Harper, MHA, CCRP, Director, Site Engagement & Relations, WCG ClinicalRamita Tandon, Chief Clinical Trials Officer, Walgreens Health, Walgreens Boots AllianceSusan Wong, PA, Principal Quality & Compliance Manager, gRED, Genentech

Using specific trials as examples, Dr Chetan Karyekar shares how Janssen Immunology is partnering with academic and community health systems to enhance diversity in clinical trials through recruitment strategies, outreach to local institutions, engaging in market research and building trustworthiness.

Speaker:

Chetan Karyekar, MD, PhD, VP, Clinical Development — Rare Diseases & Rheumatology, Janssen

Marc Boutin, JD, Global Head, Patient Engagement, Novartis

Moderated by:

Sarah Krüg, CEO/Founder, Cancer101/Health Collaboratory

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org